Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $544.15 USD
Change Today -1.93 / -0.35%
Volume 468.7K
As of 8:10 PM 07/27/15 All times are local (Market data is delayed by at least 15 minutes).

intuitive surgical inc (ISRG) Snapshot

Open
$539.25
Previous Close
$546.08
Day High
$545.50
Day Low
$537.80
52 Week High
07/22/15 - $564.86
52 Week Low
08/11/14 - $438.50
Market Cap
20.1B
Average Volume 10 Days
481.9K
EPS TTM
$14.04
Shares Outstanding
37.0M
EX-Date
--
P/E TM
38.8x
Dividend
--
Dividend Yield
--
Current Stock Chart for INTUITIVE SURGICAL INC (ISRG)

intuitive surgical inc (ISRG) Details

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States, Europe, and Asia. Its da Vinci surgical system translates a surgeon’s natural hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports. The da Vinci surgical system comprise a surgeon’s console, a patient-side cart, a 3-D vision system, da Vinci skills simulator, and Firefly fluorescence imaging product that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures. The company also manufactures EndoWrist instruments consisting of forceps, scissors, electrocautery, scalpels, and other surgical tools, which incorporate wrist joints for natural dexterity for various surgical procedures. In addition, it offers da Vinci single-site instruments and accessories that allow da Vinci Si surgical systems to work through a single incision; and EndoWrist One vessel sealers that are wristed single-use instruments intended for bipolar coagulation and mechanical transection of vessels up to 7 mm in diameter and tissue bundles that fit in the jaws of the instrument. Further, the company provides EndoWrist stapler 45 instruments, which are wristed stapling instruments intended for resection, transection and/or creation of anastomoses in general, gynecologic, and urologic surgery, as well as sells various accessory products, including sterile drapes for ensuring a sterile field during surgery, replacement 3-D stereo endoscopes, camera heads, light guides, and other items used in conjunction with the da Vinci surgical system. Intuitive Surgical, Inc. markets its products directly and through distributors. The company was founded in 1995 and is headquartered in Sunnyvale, California.

2,978 Employees
Last Reported Date: 02/6/15
Founded in 1995

intuitive surgical inc (ISRG) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $587.1K
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $405.4K
Executive Vice President of Product Operation...
Total Annual Compensation: $406.3K
Chief Commercial Officer and Executive Vice P...
Total Annual Compensation: $370.8K
Principal Accounting Officer, Vice President ...
Total Annual Compensation: $227.6K
Compensation as of Fiscal Year 2014.

intuitive surgical inc (ISRG) Key Developments

Intuitive Surgical, Inc. Announces Unaudited Consolidated Earnings Results for Second Quarter and Six Months Ended June 30, 2015; Provides Pro Outlook for the Second Half of 2015

Intuitive Surgical, Inc. announced unaudited consolidated earnings results for second quarter and six months ended June 30, 2015. For the quarter, the company reported total revenue of $586.1 million, income from operations of $173.8 million, income before taxes of $178.4 million, net income of $134.5 million or $3.56 per diluted share, non-GAAP revenue of $586.1 million, non-GAAP income from operations of $227.8 million, non-GAAP net income of $172.8 million or $4.57 per diluted share compared to the total revenue of $512.2 million, income from operations of $143 million, income before taxes of $142.6 million, net income of $104 million or $2.77 per diluted share, non-GAAP revenue of $506.5 million, non-GAAP income from operations of $195.8 million, non-GAAP net income of $140.2 million or $3.73 per diluted share for the same quarter a year ago. For the six months period, the company reported total revenue of $1,118.2 million, income from operations of $304.2 million, income before taxes of $313.1 million, net income of $231.5 million or $6.14 per diluted share, non-GAAP revenue of $1,118.2 million, non-GAAP income from operations of $412.8 million, non-GAAP net income of $307.4 million or $8.15 per diluted share compared to the total revenue of $976.9 million, income from operations of $199.6 million, income before taxes of $203.1 million, net income of $148.3 million or $3.87 per diluted share, non-GAAP revenue of $996.8 million, non-GAAP income from operations of $384.8 million, non-GAAP net income of $278.7 million or $7.28 per diluted share for the same period a year ago. The company expects its second half 2015 pro forma gross profit margin to be within a range of 67% to 68% of revenue. With regard to income tax, for the remainder of the year, the company continues to expect 2015 pro forma income tax rate to be between 28% and 30% of pretax income, depending primarily on the mix of U.S. and international profits. This forecast does not assume the reinstatement of the R&D tax credit in 2015.

Intuitive Surgical Brings Stapler Instrumentation to da Vinci Robotic-Assisted Surgical Systems in the U.S., Europe & Asia

Intuitive Surgical, Inc. announced new clearances in Europe and Asia and provided an update on the status of its EndoWrist Staplers in the United States. The da Vinci Si and Xi Surgical System staplers are the only devices of their type that provide fully wristed articulation and SmartClamp technology that detects when instrument jaws are adequately closed on target tissue. The design enables control of stapling from the surgeon console, creating a more direct relationship between clinical decision-making and instrument action. Intuitive Surgical has received clearance for stapler use on the da VinciSi and Xi Surgical Systems by various regulatory bodies in the United States, Europe and Asia.

Intuitive Surgical, Inc., Q2 2015 Earnings Call, Jul 21, 2015

Intuitive Surgical, Inc., Q2 2015 Earnings Call, Jul 21, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ISRG:US $544.15 USD -1.93

ISRG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cerner Corp $67.66 USD -0.46
CR Bard Inc $190.14 USD +2.39
Edwards Lifesciences Corp $152.72 USD -2.38
Endo International PLC $85.81 USD +0.42
Hologic Inc $37.66 USD -0.25
View Industry Companies
 

Industry Analysis

ISRG

Industry Average

Valuation ISRG Industry Range
Price/Earnings 40.7x
Price/Sales 8.9x
Price/Book 5.3x
Price/Cash Flow 40.3x
TEV/Sales 8.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INTUITIVE SURGICAL INC, please visit www.intuitivesurgical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.